The vaping cessation pill, known as varenicline, has emerged as a groundbreaking solution for young people struggling to quit vaping.Recent clinical trials highlight its potential, showing that those aged 16 to 25 who utilized this FDA-approved smoking cessation method had three times the success rate of their peers relying solely on behavioral counseling.